- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
JNJ
JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024
JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Why Is Rallybio (RLYB) Stock Up 93% Today?
Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff.
7 Dow Stocks to Buy on the Dip: March 2024
Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back.
3 Must-Have Dividend Kings for a Steady Income Stream
Discover the dividend kings with constant growth, dominating pharmaceuticals, household products and biotechnology industries.